- Division of Basic and Integrative Biological Sciences – DBIB
- Review Branch:
- Molecular and Cellular Sciences and Technologies – MCST
- Study Section:
- Cellular and Molecular Technologies – CMT
Dr. Tatiana Cohen obtained her Ph.D. in pharmacology at the University of Maryland at Baltimore, where she studied transcriptional regulation of muscle-specific genes.
She continued her postdoctoral training at the National Cancer Institute, where she developed transgenic mouse models of human disorders that result from mutations in nuclear envelope-associated proteins. She then joined the Children’s Research Institute, where she used gene microarrays and proteomic profiling and developed cell-based assays for modeling mechanisms of gene expression underlying muscle disease. Prior to joining CSR, Dr. Cohen was faculty at the Kennedy Krieger Institute with a dual appointment in the Department of Neurology at the Johns Hopkins University.